ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR

Guo, Jingyi; Huang, Shangyi; Yi, Qincheng; Liu, Naihua; Cui, Tianqi; Duan, Siwei; Chen, Jiabing; Li, Jiayu; Li, Jun; Wang, Lei*; Gao, Yong*; Nie, Guangning*广州中医药大学; y
ACS OMEGA2023-7-12DOI: 10.1021/acsomega.3c02347
7阅读
引用收藏
分享

摘要

Non-alcoholic fatty liver disease (NAFLD) has becomeserious liverdisease all over the world. At present, NAFLD caused by high calorieand fat diet is increasing. Calsyntenin-3 (Clstn3) is a transmembraneprotein that has recently been found to participate in lipid energymetabolism. But whether Clstn3 affects NAFLD lipid metabolism hasnot been analyzed. We stimulate the mice primary hepatocytes (MPHs)with oleic acid and palmitic acid (OA & PA) to establish a cellmodel. Then, potential targets, including Clstn3 gene, were validatedfor improving lipid metabolism disorder in NAFLD model mice (HFD anddb/db) by silencing and overexpressing hepatic Clstn3. Moreover, theeffects of Clstn3 on lipid homeostasis were determined by functionaldetermination, triglyceride (TG) levels, total cholesterol (TC) levels,ELISA, and qRT-PCR detection. Our results displayed that Clstn3 wasdecreased in the NAFLD mice model. Also, overexpression of Clstn3improved lipid metabolism disorders, gluconeogenesis, and energy homeostasisand reduced liver injury, inflammation, and oxidative stress injury.However, opposite results were obtained in Clstn3-silencing mice,suggesting that the Clstn3 gene is closely related to lipid metabolismdisorder in NAFLD. RNAseq expression demonstrated that Farnesoid XReceptor (FXR) expression was increased after overexpression of Clstn3.Clstn3 supplementation in FXRKO mice can improve the dysfunction causedby insufficient FXR, suggesting that Clstn3 can improve the NAFLDlipid metabolism disorder to some extent through FXR, which may providea new method for the treatment of NAFLD.

学科与关键词

关键词
FARNESOID X RECEPTORLIVER-DISEASEBILE-ACIDALPHAPATHOGENESISINFLAMMATION
相关
加载中…
  • Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor
    Xu, Wenjing; Cui, Changting; Cui, Chunmei; Chen, Zhenzhen; Zhang, Haizeng; Cui, Qinghua; Xu, Guoheng; Fan, Jianglin; Han, Yu; Tang, Liangjie; Targher, Giovanni; Byrne, Christopher D.; Zheng, Ming-Hua*; Yang, Liming*; Cai, Jun*; Geng, Bin*Hepatology, 2022, 76(6): 1794-1810.被引 19
  • A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR)
    Zhou, Shipeng; You, Huimin; Qiu, Shuting; Yu, Dawei; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*Biomedicine and Pharmacotherapy, 2022, 154: 113577.被引 16
  • Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro
    Zheng, Yi; Zhao, Jian; Miao, Deyu; Xu, Tingting; Wang, Liziniu; Liu, Changhui; Gao, Yong; Yu, Lili; Shen, Chuangpeng*Biomedicine and Pharmacotherapy, 2023, 164: 114957.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS OMEGA
发表日期
2023-07-12
卷期
第 8 卷, 第 29 期
页码
26158-26169
DOI
10.1021/acsomega.3c02347
成果收录
SCIE

作者

  • G

    Guo, Jingyi (第一作者)

    guangzhou univ chinese med · 2

  • H

    Huang, Shangyi

    guangzhou univ chinese med

查看全部 12 位作者收起作者
  • Y

    Yi, Qincheng

    2 · guangzhou univ chinese med

  • L

    Liu, Naihua

    guangzhou univ chinese med

  • C

    Cui, Tianqi

    guangzhou univ chinese med

  • D

    Duan, Siwei

    guangzhou univ chinese med

  • C

    Chen, Jiabing

    guangzhou univ chinese med

  • L

    Li, Jiayu

    guangzhou univ chinese med

  • L

    Li, Jun

    2 · guangzhou univ chinese med

  • W

    Wang, Lei (通讯)

    2 · guangzhou univ chinese med

  • G

    Gao, Yong (通讯)

    guangzhou univ chinese med

  • N

    Nie, Guangning (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417